MetLife Investment Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $105K | Buy |
|
|||||
|
2024
Q3 | $64.1K | Sell |
|
|||||
|
2024
Q2 | $132K | Buy |
|
|||||
|
2024
Q1 | $224K | Buy |
|
|||||
|
2023
Q4 | $108K | Hold |
|
|||||
|
2023
Q3 | $59.2K | Hold |
|
|||||
|
2023
Q2 | $153K | Hold |
|
|||||
|
2023
Q1 | $192K | Hold |
|
|||||
|
2022
Q4 | $273K | Hold |
|
|||||
|
2022
Q3 | $315K | Buy |
|
|||||
|
2022
Q2 | $178K | Buy |
|
|||||
|
2022
Q1 | $99.6K | Sell |
|
|||||
|
2021
Q4 | $168K | Buy |
|
|||||
|
2021
Q3 | $164K | Sell |
|
|||||
|
2021
Q2 | $351K | Buy |
|
|||||
|
2021
Q1 | $342K | Sell |
|
|||||
|
2020
Q4 | $610K | Hold |
|
|||||
|
2020
Q3 | $427K | Buy |
|
|||||
|
2020
Q2 | $486K | Buy |
|
|||||
|
2020
Q1 | $107K | Buy |
|